baber/WOPTO huggingface dataset:
Patent EP-0781305-B1 (EP)
Inventor: CARDINAUD DENIS
IPC: C08K5/544
Filed: 1995-09-14
Granted: 2001-11-14
Abstract: PCT No. PCT/FR95/01182 Sec. 371 Date May 2, 1997 Sec. 102(e) Date May 2, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/08529 PCT Pub. Date Mar. 21, 1996The present invention relates to an aqueous silicone dispersion, capable of being cross-linked into an elastomer by removing water and optionally alcohol and/or carboxylic acid, said dispersion being based on at least one polyorganosiloxane (A) having at least two condensable or hydrolysable ORa groups per molecule wherein Ra=H or alkyl, as well as at least one surficant (B). The technical problem consisting of perfecting a stable dispersion capable of being cross-linked into an elastomer that is highly adhesive on any support and that has suitable and economic mechanical properties is solved since this dispersion includes an amino-functionalised polyorganosiloxane (C) of the DTT(N)(OMe) resin type redistributed with aminoethylaminopropyltrimethoxysilane, optionally at least one hydroxylated and/or alkoxylated silicone resin (D), optionally at least on alkoxysilane (E) donating the -ORa terminals of the polydiorganosiloxane (A), optionally at least on condensation catalyst (F) and optionally at least one optionally siliceous filler (G).
Patent EP-0786972-B1 (EP)
Inventor: MARIN MICHAEL L
IPC: A61M29/00
Filed: 1995-09-27
Granted: 2004-01-28
Abstract: An apparatus for deploying stents for use in connection with endoluminally bypassing blood flow through an aneurysm in the vicinity of a branched blood vessel is provided. The apparatus is movably mounted on a catheter and includes a deployment wire (80) for effecting axial movement. It includes a plurality of first length arms (82) and a plurality of second length arms (84), links and wings (52 a,b,c,d) which form a support surface for the stent. The wings are also connected to a rigid portion on the catheter, and the arrangement is such that on deployment the wings connected to the first length arms are radially outwardly displaced more than the wings connected to the second length arms, when the deployment wire is actuated.
Patent EP-0743903-B1 (EP)
Inventor: ZIMMER PETER
IPC: B41F35/00
Filed: 1995-12-12
Granted: 1997-10-08
Abstract: PCT No. PCT/AT95/00243 Sec. 371 Date Aug. 9, 1996 Sec. 102(e) Date Aug. 9, 1996 PCT Filed Dec. 12, 1995 PCT Pub. No. WO96/18503 PCT Pub. Date Jun. 20, 1996A storage system for round stencils, in particular those used in the textile industry, has two or several holders for releasably holding the round stencils. The holders of the storage system may be moved by a drive, preferably all together. Also disclosed is an application system which has besides the production machine and the storage system a separate washing installation for cleaning the round stencils taken from the production machine. In the washing installation, the round stencils are sprayed from the inside and cleaned from the outside, in particular by brushes, at the same time as they are rotated.
Patent EP-0804183-B1 (EP)
Title: Use of creatine or creatine analogs for the treatment of huntigton's disease, parkinson's disease and amyotrophic lateral sclerosis
Inventor: KADDURAH-DAOUK RIMA
IPC: A61K31/66
Filed: 1995-11-07
Granted: 2006-07-05
Abstract: The present invention relates to the use of creatine compounds including creatine, creatine phosphate or analogs of creatine, such as cyclocreatine, for treating diseases of the nervous system. Creatine compounds can be used as therapeutically effective agents against a variety of diseases of the nervous system such as diabetic and toxic neuropathies, peripheral nervous system diseases, Alzheimer disease, Parkinson's disease, stroke, Huntington's disease, motor neuron disease, traumatic nerve injury, multiple sclerosis, dysmyelination and demyelination disorders, and mitochondrial diseases. The Creatine compounds which can be used in the present method include: (1) creatine, creatine phosphate and analogs of these compounds which can act as substrates or substrate analogs for creatine kinase; (2) bisubstrate inhibitors of creatine kinase comprising covalently linked structural analogs of adenosine triphosphate (ATP) and creatine; (3) creatine analogs which can act as reversible or irreversible inhibitors of creatine kinase, and (4) N-phosphorocreatine analogs bearing non-transferable moieties which mimic the N-phosphoryl group.
Patent EP-0891135-B1 (EP)
Inventor: PALLAS NORMAN ROBERT
IPC: C05G3/70
Filed: 1996-03-20
Granted: 2002-06-12
Abstract: Stable, concentrated nonaqueous suspensions of water-soluble solids are prepared by using water-miscible organic liquid carriers, preferably lower alkadiols in conjunction with a specific three-component surfactant system, i.e., a system comprising a nonionic polymeric viscosity improver surfactant; an anionic surfactant; and a nonionic surfactant having a bulky hydrophobic substituent group.
Patent EP-0780326-B1 (EP)
Inventor: SCHIESSER RICARDO N
IPC: B65G47/26
Filed: 1996-12-21
Granted: 2000-03-22
Abstract: The endless mechanism has a top surface (12) for the transport of the goods and along it are successive buffer sections (A-D) to halt the latter. These have lengthwise beams (18) alongside and parallel to the mechanism, and which are lifted by drive mechanisms (30) to bring the brake surface above that of the transport mechanism (12). The adjacent beams are linked together in a chain, so that to accumulate the goods in a particular buffer section, the respective beam is lifted by its drive mechanism so that it slopes upwards in the transport direction and above the surface (12). After braking the goods to a halt, the entire braking surface can be lifted above the mechanism surface (12), the surfaces of the preceding beams being simultaneously and partly lifted.
Patent EP-0720974-B1 (EP)
Inventor: PENAUD JEAN
IPC: C05F17/00
Filed: 1996-01-08
Granted: 2002-11-27
Abstract: Complex of non-pathogenic Bacillus and Lactobacillus strains capable of converting a nitrogen source to bacterial protein are new, where the nitrogen source is selected from inorganic nitrogen cpds., esp. ammonia, nitrates and nitrites, and organic nitrogen cpds., e.g. urea, urates, amino acids, nitrogen-contg. bases and any other nitrogen cpds. of low mol. wt.
Patent EP-0736317-B1 (EP)
Inventor: LEE HYOSONG
IPC: B01D21/00
Filed: 1996-03-19
Granted: 2002-01-16
Abstract: The invention relates to a method and an apparatus for the gravitational separation of fine particles out of a liquid. The liquid containing the particles which are to be separated is conducted with laminar flow through the gaps between a plurality of closely separated, essentially horizontally orientated surface-forming elements (16). The liquid flow through the gaps is interrupted when the particle concentration in the liquid which has flowed through the gaps exceeds a predetermined value. The surface-forming elements (16) are repositioned to an essentially vertical discharging position in order to remove the particle collection present on the surface-forming elements. The surface-forming elements (16) are then returned to the essentially horizontal working position and a new gravitational separation cycle begins. <IMAGE>
Patent EP-0807039-B1 (EP)
Inventor: GRAEBER JOHANNES
IPC: B60T8/48
Filed: 1996-01-30
Granted: 1999-08-04
Abstract: A process is disclosed for operating a car motion stabilising and/or drive slip regulating antilocked motor vehicle braking system (FSR/ASR). The actuating unit (1) of the braking system may be actuated by a brake pedal (4) whose actuating path is determined by a pedal position sensor (11). In the event of regulation, a pressure value that corresponds to the hydraulic pressure of the braking circuit (I or II) to which the driver applies a pressure is associated with the output signal of the pedal position sensor (11).
Patent EP-0820432-B1 (EP)
Inventor: GIERSKCKY KARL ERIK
IPC: A61K41/00
Filed: 1996-03-08
Granted: 2001-06-13
Abstract: PCT No. PCT/GB96/00553 Sec. 371 Date Dec. 5, 1997 Sec. 102(e) Date Dec. 5, 1997 PCT Filed Mar. 8, 1996 PCT Pub. No. WO96/28412 PCT Pub. Date Sep. 19, 1996The invention provides a pharmaceutical compositions comprising a compound of formula I:R22N-CH2COCH2-CH2CO-OR1(I)wherein, R1 and R2 have any of the values defined in the specification; or a salt thereof; and a pharmaceutically acceptable carrier or excipient. The invention also provides a method for the diagnosis or photochemotherapeutic treatment of disorders or abnormalities of external or internal surfaces of the body using such compounds or salts.
Patent EP-0759111-B1 (EP)
Inventor: HAMBERGER PETER
IPC: E04F15/22
Filed: 1996-03-11
Granted: 2001-07-11
Abstract: The invention concerns an elastic multi-layer spring floor, e.g. a spring floor, comprising a plurality of spring supports (130) aligned parallel to one another and separated by lateral gaps, on which load-distributing boards (132) are supported over a counterfloor board layer (124) laid at right angles to the spring supports. In order to modify the deflexion trough, in particular to reduce the deflexion trough in a direction perpendicular to the extent of the spring supports (130), the load-distributing boards (132) are subdivided into strips in such a way as to produce load distributing board segments (132) with a maximum lateral gap between adjacent underlying spring supports (130). The reinforcing ribs (134) can be chamfered at both ends, the projecting end faces and the withdrawn end faces on one side of the load-distribution module being parallel to one another although cut in opposing directions.
Patent EP-0817969-B1 (EP)
Inventor: WISCHIK CLAUDE MICHEL
IPC: A61K31/5415
Filed: 1996-03-25
Granted: 2002-07-31
Abstract: The present invention relates to novel methods for the detection of substances capable of modulating or inhibiting pathological tau-tau protein association and pathological neurofilament aggregation. The methods of the present invention are particularly useful in screening substances for the prophylaxis and treatment of Alzheimer's disease, motor neuron disease, Lewy body disease, Pick's disease and progressive supranuclear palsy. In addition, substances capable of selectively inhibiting pathological aggregates while preserving normal cytoskeletal function are described.
Patent EP-0777874-B1 (EP)
Inventor: JANSSENS JAN ALBERT MARIA
IPC: G06F1/10
Filed: 1996-05-31
Granted: 2003-03-12
Abstract: Un circuit pipeline contient une cascade d'étages dont chacun comporte un registre initial suivi d'un circuit logique combinatoire. Les registres sont synchronisés. Au début de chaque période d'horloge, les données du registre initial sont mises à jour. Ensuite, pendant la période d'horloge, des données se propagent à partir du registre initial, le long d'un chemin passant à travers les circuits logiques combinatoires, jusqu'au registre initial de l'étage suivant, où elles sont stockées au début du cycle suivant. Il y a plusieurs autres registres sur le chemin, dans lesquels les données sont stockées à des stades intermédiaires du cycle d'horloge, pendant que les données sont conservées dans le registre initial. Les différences de temps de propagation le long des différentes branches du chemin sont donc éliminées sans qu'augmente le nombre de cycles d'horloge nécessaire pour faire passer des données dans le circuit pipeline. Cela réduit le nombre de distorsions transitoires qui consomment de l'énergie, sans affecter le fonctionnement du circuit.
Patent EP-0825867-B1 (EP)
Inventor: ELSON CLIVE M
IPC: A61K38/00
Filed: 1996-05-06
Granted: 2003-12-10
Abstract: The invention relates to a method of treating patients to minimize post-surgical adhesions and a kit useful in the method of the invention. The method is based on the finding that N,O-carboxymethylchitosan (NOCC) has advantageous properties as a wound healing lavage and coating. A NOCC solution is particularly effective as a post-surgical lavage and when used in conjunction with a NOCC gel coating, wound healing rate is unchanged while the number and severity of adhesions is greatly reduced.
Patent EP-0832131-B1 (EP)
Inventor: LIGHT WILLIAM R
IPC: C07K14/805
Filed: 1996-06-05
Granted: 2000-02-16
Abstract: A method for separating unmodified hemoglobin from cross-linked hemoglobin in a hemoglobin solution. The method involves contacting the hemoglobin solution with a least one dissociating agent to form a dissociation solution wherein unmodified tetrameric hemoglobin is dissociated to form hemoglobin dimers. The hemoglobin dimers are then separated from the dissociation solution, while retaining the cross-linked hemoglobin in the dissociation solution.
Patent EP-0876143-B1 (EP)
Inventor: SHOHAMI ESTHER
IPC: A61K31/22
Filed: 1996-09-10
Granted: 2006-06-28
Abstract: Pharmaceutical compositions are described for preventing TNF toxicity, comprising as active ingredient the stereospecific (+) enantiomer having 3S, 4S configuration of delta 6 tetrahydrocannabinol type compounds. The compositions are particularly effective in alleviating and even preventing neurotoxicity due to elevated levels of TNF, including septic shock, cachexia and trauma. They are also effective in the treatment of certain chronic degenerative diseases characterized by TNF production, including autoimmune diseases.
Patent EP-0851978-B1 (EP)
Inventor: GEHLING JOHANNES
IPC: F02M31/04
Filed: 1996-09-18
Granted: 2000-04-26
Abstract: A control system for a diesel-operating internal combustion engine has in a cast-plastic housing heater connected to the air supply line and upstream of an air mixer and an adjusting device in the diesel fuel line leading to the mixer. A limiter is provided between an air control device in the air supply line and the mixer can include a cylindrical gate around which the air is guided and an air control plunger at the upstream end of that body.
Patent EP-0852531-B1 (EP)
Title: Procede de fabrication d'articles extrudes colores
Inventor: LOCKE JOHN S
IPC: B29C48/05
Filed: 1996-09-25
Granted: 2002-06-05
Abstract: Ce procédé de fabrication d'articles extrudés colorés, dans lequel chaque colorant est contenu dans un concentré de matière colorante, consiste à fournir chaque concentré dans une extrudeuse (8), au moyen d'un dispositif d'alimentation (2, 4, 6) gravimétrique séparé, et à mélanger à chaud, dans l'extrudeuse, les concentrés de matière colorante et un polymère thermoplastique, avant extrusion.
Patent EP-0893956-B1 (EP)
Inventor: CHUNG SEUN YUNG
IPC: A61F5/40
Filed: 1996-12-11
Granted: 2003-08-27
Abstract: PCT No. PCT/KR96/00238 Sec. 371 Date Jun. 12, 1998 Sec. 102(e) Date Jun. 12, 1998 PCT Filed Dec. 11, 1996 PCT Pub. No. WO97/21363 PCT Pub. Date Jun. 19, 1997Men's pants (shorts or briefs) have a Y type separation band (2) or a U type separation band (22) inside thereof together with separation pads (7, 77) to separate the testicles from the body, the penis from the testicles, and the penis from both hips. Complete separation around the male genitals is achieved without effort by wearing these pants. A penis band (3) formed with an elastic band (4, 44) and clips (5, 55) is sewn to a center part of a waist band (6) in an I shape. A penis hole (14) can be adjusted by moving the two clips (5, 55) up and down according to the individual location and size of the penis (101). A lower part (88) below the clip (5) helps to increase separation between the testicles and the penis.
Patent EP-0826429-B1 (EP)
Inventor: FELDKAEMPER RICHARD
IPC: B05C1/08
Filed: 1997-07-14
Granted: 2002-05-08
Abstract: The adhesive applicator comprises rollers (6,7) which are mounted on a support plate (3) in a suspended and free-floating fashion. The rollers, together with a housing (26), form an adhesive chamber. The support plate is mounted laterally to the rollers, and swivelable about a vertical shaft in the machine frame (1). The support plate has support pins (24,25) on which the housing is removably attached. The housing is provided with a laterally over-hanging bracket which is lockable to the support pins.
Patent EP-0915054-B1 (EP)
Inventor: MILLER GERT DR
IPC: B67D7/22
Filed: 1997-09-04
Granted: 1999-12-15
Abstract: On the pressure side of the fuel pumps (4), individual pipelines (5a) from each of the different fuel types are connected to a common pipeline (5b) prior to a fuel measurement device (7), a delivery hose (3) and a delivery valve (2). In addition each of the pumps has a non-return valve (6) to prevent any unwanted return and mixing of fuel types. A further development is a supply line after the meter (7) that can route the fuel according to its type to a separate channel within a multichannel delivery hose. An Independent claim is included for the determination of dispensed fuel cost.
Patent EP-0909857-B1 (EP)
Inventor: KASSNER KLAUS DR
IPC: E04B2/02
Filed: 1997-10-16
Granted: 2001-01-03
Abstract: Holes (6,7) form channels through the brick, between which are connecting webs (8) The ratio between the width of the webs measured in the direction of the outside walls (2,3) and the width of the channels, measured in the same direction, is 1:1.3 to 1:1.8. Width of the webs is preferably 3.5 - 4.1 mm and the channels take up 55-60% of the brick cross section.
Patent EP-0826955-B1 (EP)
Inventor: FARMILO JAMES A
IPC: G01N33/543
Filed: 1994-02-03
Granted: 2002-05-22
Abstract: There is disclosed an automated process for immunocytochemical staining of biological materials using ligand pairing. The apparatus includes an array of sample cells interconnected with reagent supply and drainage lines. Each cell encloses a fluid chamber into which a sample substrate is inserted. The face of the substrate onto which a biological sample is mounted faces into a fluid well. The cell includes a cell head having a chamber to receive therein a solid support matrix releasably containing a ligand to be contacted with the sample. The chamber in the cell head is in flow communication with the fluid well so that when the ligand is released from the matrix it flows into the fluid well thereby contacting the mounted biological sample. The ligand support matrix may be gelatin or wax. The cell body and cell head are differentially heated or cooled so that the mounted sample may be held at the preferrend temperature for the reaction of interest and the cell head may be heated to a temperature sufficient to cause thermal degradation of the matrix to effect release of the ligand. Control electronics is provided for sensing and controlling the temperature of the various cell parts and for programmable control of reagent supply to the cells. <IMAGE>
Patent EP-0841016-B1 (EP)
Inventor: CABANIS LOUIS
IPC: A43B5/16
Filed: 1997-11-04
Granted: 2002-01-30
Abstract: Assembly comprises creating a first sub-assembly by joining together an upper (11) which is at least partially supple and an inner sole (13) using nails (15), and then making a second sub-assembly by adding an outer sole (2), which is fixed in place by rivets (18). The second sub-assembly is then joined to the rigid frame (1) by nuts and bolts (5a, 5b). The second sub-assembly can be adjusted relative to the frame by means of a transverse elongated slot (1b) for the front bolt.
Patent EP-0841518-B1 (EP)
Inventor: ZAGOROFF DIMITER S
IPC: F04F5/46
Filed: 1997-11-07
Granted: 2003-02-05
Abstract: A jet pump for a heat gun includes an elongate hollow pump body (36) lying along a longitudinal axis. The pump body has an inlet (37), a mixing section (40) and an outlet. A nozzle unit (26) is axially aligned with the inlet for directing pressurized fuel into the inlet of the pump body. Movement of the pressurized fuel into the inlet causes air to be drawn into the inlet to mix with the fuel within the pump body. A disk shaped air diverter (30) is axially spaced away from the inlet of the pump body. The diverter has a length and a diameter. The diameter of the diverter is greater than the length of the diverter and larger than the inlet of the pump body. A housing (33) is radially spaced from and surrounds the diverter forming a first annular gap therearound for air outside the housing to pass therethrough. The air moves around the diverter then changes direction between the diverter and the inlet of the pump body before entering the inlet.
Patent EP-0897955-B1 (EP)
Inventor: KATSUBE SHUNICHI
IPC: C08K3/00
Filed: 1997-02-14
Granted: 2002-11-27
Abstract: Composition de résine polyester qui contient 21 à 29 % en poids d'un constituant résine comportant un polyester obtenu à partir d'acide fumarique, de néopentyl glycol et de propylène glycol, et un agent de polymérisation comprenant de l'hydroperoxyde de cumène, 52 à 60 % en poids d'au moins un composé inorganique qui est soumis à la déshydratation à 150 °C ou plus en tant que charge inorganique, et 15 à 23 % en poids d'un agent de renforcement. Les interrupteurs dotés d'un élément structural isolant constitué de la composition susmentionnée possèdent des propriétés d'isolation améliorées après la coupure d'un fort courant électrique. Spécifiquement, ladite composition sert à prévenir la formation d'une peau constituée du constituant résine sur la surface d'un élément moulé produit à partir de ladite résine et empêche également la disparition, de cette surface, du composé inorganique qui sert à convertir le carbone libre et les valeurs métalliques en oxydes non conducteurs, par des réactions avec un gaz de décomposition produit par la chaleur de l'arc, ce qui garantit ainsi les propriétés d'isolation après la coupure d'un courant électrique.
Patent EP-0948310-B1 (EP)
Inventor: DUPUIS CHRISTINE
IPC: A61Q5/00
Filed: 1997-10-27
Granted: 2002-12-11
Abstract: The invention concerns a cosmetic composition for treating keratinous fibers, in particular hair, containing at least an anionic or non-ionic polymer and at least one silicon comprising at least a carboxylic acid function, as well as the method for treating keratinous fibers using this composition.
Patent EP-0906448-B1 (EP)
Inventor: GIORDANO ANTONIO
IPC: C12N15/11
Filed: 1997-04-03
Granted: 2009-02-25
Abstract: The invention provides diagnostic and prognostic methods which comprise determining the level of expression of the tumor suppressor gene pRb2/p130, because the relative level of pRb2/p130 expression correlates with the presence of cancer, tumor grade and patient prognosis. These methods may be used to detect cancer, to make treatment decisions, to predict patient outcome, and to predict the risk of cancer in disease-free individuals. The invention further provides methods for the detection of mutations and polymorphisms in the pRb2/p130 gene, which may be used to characterize genetic events associated with tumor formation, to trace the parental origin of mutations, to identify carriers of germline mutations and to identify individuals with a predisposition to cancer.
Patent EP-1014844-B1 (EP)
Inventor: NORDIN RUDOLF
IPC: A47L13/254
Filed: 1997-04-23
Granted: 2004-06-23
Abstract: The invention relates to a tiltable mop frame for cleaning floors, etc., which comprises a preferably elongated plate, which is provided with a cleaning cloth on the underside and is intended to be pushed forward and pulled backwards over the surface, which is to be cleaned and has an elongated handle (2) which is hingeably (3) fastened to the upper side of the plate (1). The mop is characterized in that the underside of the plate (1) is provided with an elongated protrusion (6) which extends crosswise to the forward and backward direction of the mop during use and is arranged in the middle of the plate (1).
Patent EP-0901581-B1 (EP)
Inventor: LARSSON PER
IPC: F16H33/18
Filed: 1997-06-02
Granted: 2002-04-24
Abstract: Dans un accouplement hydraulique (1) comportant un carter (2) enserrant un rotor (3) et une roue de turbine (4) montée rotative dans ledit carter, la roue de turbine est pourvue, sur sa face tournée vers le carter, de moyens de raclage (10) destinés à éliminer par raclage les impuretés qui se sont déposées sur la paroi intérieure du carter.